Share a Resource
Submit material for the education materials pages. Material will be reviewed by the Communications Committee before posting.

IVIG


IDF takes on IVIG access issues in Congress

CIS endorses the efforts of the IDF to ensure IVIG access for all appropriate patients.

CIS responds to Coventry - HealthAmerica adopting a “Fail First” single brand restrictive formulary policy for IVIG treatments.